Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Immunoturbidimetric Test for D-Dimer Performed on Clinical Chemistry Systems

By LabMedica International staff writers
Posted on 05 May 2009
A newly designed particle-enhanced immunoturbidimetric test for D-Dimer is designed for use on automated clinical chemistry systems. More...
D-Dimer tests are used for exclusion of deep vein thrombosis (DVT) of the leg.

The new D-Dimer FS immunoturbidimetric test has a cut-off value of 0.5 µg FEU/ml (fibrinogen equivalent units per milliliter) and shows good diagnostic sensitivity ensuring that 98 % of patients with DVT are found true-positive. The two-component reagent is liquid-stable and ready to use. The test covers a wide measuring range up to 8.7 µg FEU/ml and stands out for its high prozone security up to 50 µg FEU/ml. D-Dimer FS shows excellent calibration and on-board stability up to six weeks.

D-Dimer FS is a product of DiaSys Diagnostic Systems (Holzheim, Germany), a company that develops, manufactures, and distributes a full range of diagnostic reagents for clinical chemistry and including controls and calibrators. The company focuses on liquid-stable, ready-to-use reagents for measurement of enzymes and substrates, and immunoturbidimetric tests for the measurement of specific proteins.

The company's current product range lists more than 80 reagents in convenient packages for routine and special diagnostics on photometers or automated analyzers. The product range is completed by clinical chemistry analyzers and point-of-care instruments for diabetes monitoring.

Related Links:

DiaSys Diagnostic Systems





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Electrolyte Analyzer
BKE-B
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.